Your browser doesn't support javascript.
loading
A novel germline gain-of-function variant in PIK3CD.
Rae, William; Gao, Yifang; Ward, Daniel; Mattocks, Christopher J; Eren, Efrem; Williams, Anthony P.
Afiliação
  • Rae W; Department of Immunology, University Hospital Southampton NHSFT, Southampton, UK; NIHR Wellcome Trust Clinical Research Facility Southampton, University Hospital Southampton NHSFT, University of Southampton, UK. Electronic address: will.rae@nhs.net.
  • Gao Y; NIHR Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK; Wessex Investigational Science Hub Laboratory, University of Southampton, University Hospital Southampton NHSFT, Southampton, UK.
  • Ward D; Wessex Investigational Science Hub Laboratory, University of Southampton, University Hospital Southampton NHSFT, Southampton, UK; Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK.
  • Mattocks CJ; Wessex Investigational Science Hub Laboratory, University of Southampton, University Hospital Southampton NHSFT, Southampton, UK; Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK.
  • Eren E; Department of Immunology, University Hospital Southampton NHSFT, Southampton, UK.
  • Williams AP; Department of Immunology, University Hospital Southampton NHSFT, Southampton, UK; NIHR Cancer Research UK Experimental Cancer Medicine Centre, Southampton, UK; Wessex Investigational Science Hub Laboratory, University of Southampton, University Hospital Southampton NHSFT, Southampton, UK.
Clin Immunol ; 181: 29-31, 2017 08.
Article em En | MEDLINE | ID: mdl-28578023
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Classe I de Fosfatidilinositol 3-Quinases / Síndromes de Imunodeficiência Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Classe I de Fosfatidilinositol 3-Quinases / Síndromes de Imunodeficiência Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article